Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CDK inhibitors
Biotech
Pfizer's hotly tipped breast cancer prospect records phase 2 win
The CDK4 inhibitor improved progression-free survival in second-line breast cancer, but Pfizer's sights are locked onto earlier lines of treatment.
Nick Paul Taylor
Mar 17, 2026 8:40am
Kronos lays off 83% of staff, changes CEO after clinical setback
Nov 27, 2024 9:56am
Genentech pays $850M upfront for Regor's CDK inhibitors
Sep 30, 2024 5:30am
Kronos launches second round of layoffs in 5 months
Mar 8, 2024 10:35am
BeiGene offers up $1.3B in biobucks for preclinical cancer drug
Nov 21, 2023 7:13am
Bayer inks Cedilla cancer deal to join pack chasing Pfizer
Jun 1, 2023 7:30am
